India: Medicos in Jharkhand Protest Against Violence, and More

Hi Renukaprasad A R, Top Stories of the Day: India: Medicos in Jharkhand Protest Against Violence USFDA Approves Docetaxel Injection for Various Cancers NHS Behavior Change Program Reduces Risk of Diabetes by 20% India: NMC Guidelines to Issue NOC for Foreign Medicos Webinar: Midface Reconstruction Healthcare headlines that matter, brought to you every day by Docplexus Health Minute! Watch News Docplexus: One of the world's largest online communities of Doctors Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

A Structured Management Approach for Diabetic Xerosis

Dear Dr. Renukaprasad A R, Skin issues in diabetes mellitus (DM) patients are associated with microangiopathy, protein glycosylation, neuropathy, and other DM complications.1 Xerosis and callus are early-stage skin disorders that increase the risk of diabetic ulceration.2 DM patients who have their disease under control and use proper skincare are less likely to develop skin diseases.1 Read this article that discusses the preventive measures and treatment approaches for DM-associated xerosis in detail. Read More References - Ragunatha S et al., Indian J Dermatol. 2011 Mar;56(2):160-4. de Macedo GM et al., Diabetol Metab Syndr. 2016 Aug 30;8(1):63. Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Real-World Evidence for the Benefits of Ramucirumab in mNSCLC

Dear Dr. Renukaprasad A R, Ramucirumab, in combination with docetaxel, is indicated for locally advanced or metastatic non-small cell lung cancer (mNSCLC) patients with disease progression on or after platinum-based chemotherapy. Join us TODAY at 04:30 PM and 09:30 PM IST to get more insights on ramucirumab as a second-line treatment option for mNSCLC following immune checkpoint inhibitors and chemotherapy! Looking forward to your active participation in the discussion! Highlights: Opening remarks - Prof. Marwan Ghosn Second-line treatment option for mNSCLC patients following chemotherapy and immune checkpoint inhibitor: Analysis from German hospitals - Prof. Claas Wesseler Clinical case presentation - Dr. Emad Anwar Panel discussion - Moderator:Dr. Shyam Aggarwal Join Now Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Ramucirumab: A Treatment Milestone for Metastatic NSCLC

Dear Dr. Renukaprasad A R, Lung cancer has now become the most common cause of cancer-related death in men and the second most common cause of death in women, with the number of deaths from lung cancer estimated at 135,000 patients per year. More people are dying from lung cancer than from prostate, breast, brain, and colorectal cancers combined. Join us for an exclusive webinar on 2nd March 2023 at 4:30 PM and 9:30 PM IST with our renowned International experts in oncology, who will discuss clinical evidence for ramucirumab as a second-line treatment option for metastatic non-small cell lung cancer (mNSCLC) patients following immune checkpoint inhibitor and chemotherapy. The experts will answer your questions live. We look forward to your participation in this informative discussion! I'm Interested Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

India Likely to Miss Target for Health SDGs: Lancet Study, and More

Dear Dr. Renukaprasad A R, Top Stories of the Day: India Likely to Miss Target for Health SDGs: Lancet Study USFDA Nod for Generic Drug for High BP USFDA: Guillain-Barre syndrome, a Possible Risk of RSV Vaccine Head Injuries Could be a Risk Factor for Brain Cancer Webinar: Added Value of Weight-bearing MRI in Evaluation of Spine Healthcare headlines that matter, brought to you every day by Docplexus Health Minute! Watch News Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Diabetic Xerosis Management: Experts Share Their Clinical Experience

Dear Dr. Renukaprasad A R, Common skin disorders, like dry skin and pruritus, can lead to significant complications, and these skin disorders are generally neglected and underdiagnosed in diabetic patients.1 Dermo-cosmetic management with urea is a widely accepted approach to avoid the progression of skin lesions in DM patients.1 We invite you to participate in an exclusive webinar organized by Galderma and Docplexus on 2nd March 2023 at 8:00 PM IST to interact with the experts as they discuss their clinical experiences of addressing xerosis in diabetic patients. Save the Date Reference - de Macedo GM et al., Diabetol Metab Syndr. 2016 Aug 30;8(1):63. Docplexus: One of the world's largest online communities of Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*